Position in JNJ
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$108,699
+$4,079 QoQ
Shares Held
428
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#4,554
of 4,663 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DiNuzzo Private Wealth, Inc. holds $599,622 across 12 Drug Manufacturers - General names. JNJ ranks #4 (18.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
133 | $159,524 | |
| 2 | ABBV |
AbbVie Inc.
|
489 | $123,051 | |
| 3 | MRK |
Merck & Co., Inc.
|
930 | $119,505 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
428 | $108,699 | |
| 5 | PFE |
Pfizer Inc
|
1,122 | $27,017 | |
| 6 | AMGN |
Amgen Inc
|
46 | $16,657 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
102 | $12,886 | |
| 8 | SNY |
Sanofi
|
299 | $12,755 |
All Filings in JNJ
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $108,699 | 428 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $104,620 | 428 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $129,964 | 628 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $116,443 | 628 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $100,662 | 659 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $108,791 | 656 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $92,122 | 637 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $112,631 | 695 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $99,681 | 682 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $103,456 | 654 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $102,351 | 653 | Shares | Sole | 2024-05-06 | |
| No filing history on record for this holder in this stock. | ||||||